552 related articles for article (PubMed ID: 15606390)
21. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation.
Mörk H; Al-Taie O; Berlin F; Kraus MR; Scheurlen M
Scand J Gastroenterol; 2007 Jan; 42(1):23-7. PubMed ID: 17190758
[TBL] [Abstract][Full Text] [Related]
22. [Endoscopic argon plasma coagulation of Barrett mucosa].
Brand B; Porthun M; von Schrenck T; Matsui U; Bohnacker S; Jäckle S; Thonke F; Seitz U; Soehendra N
Zentralbl Chir; 2000; 125(5):437-42. PubMed ID: 10929628
[TBL] [Abstract][Full Text] [Related]
23. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.
Dumoulin FL; Terjung B; Neubrand M; Scheurlen C; Fischer HP; Sauerbruch T
Endoscopy; 1997 Oct; 29(8):751-3. PubMed ID: 9427496
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
26. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
27. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
28. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
29. Management of Barrett's oesophagus, dysplasia and early adenocarcinoma.
Pech O; Gossner L; May A; Ell C
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):267-84. PubMed ID: 11355915
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
31. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
32. Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience.
May A; Gossner L; Günter E; Stolte M; Ell C
Endoscopy; 1999 Aug; 31(6):497-500. PubMed ID: 10494693
[TBL] [Abstract][Full Text] [Related]
33. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D
Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
[TBL] [Abstract][Full Text] [Related]
34. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
35. [Endoscopic treatment of Barrett's oesophagus].
Boyer J
Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
[TBL] [Abstract][Full Text] [Related]
36. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.
Luman W; Lessels AM; Palmer KR
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):627-30. PubMed ID: 8853248
[TBL] [Abstract][Full Text] [Related]
37. Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow.
Bozymski EM
Am J Gastroenterol; 2007 May; 102(5):1128-9; author reply 1129-30. PubMed ID: 17489788
[No Abstract] [Full Text] [Related]
38. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Panjehpour M; Overholt BF
Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.
Ackroyd R; Tam W; Schoeman M; Devitt PG; Watson DI
Gastrointest Endosc; 2004 Jan; 59(1):1-7. PubMed ID: 14722539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
